Molecular docking reveals a novel binding site model for fentanyl at the μ-opioid receptor

Journal of Medicinal Chemistry

Volumn 43, Issue 3, 2000, Pages 381-391

  Subramanian, Govindan ^a   Paterlini, M Germana ^a   Portoghese, Philip S ^a   Ferguson, David M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA HYDROXYMEFENTANYL; CARFENTANIL; FENTANYL; FENTANYL DERIVATIVE; MEFENTANYL; MU OPIATE RECEPTOR; R 30490; REMIFENTANIL; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONFORMATIONAL TRANSITION; DRUG BINDING; HUMAN; LIGAND BINDING; MOLECULAR INTERACTION; MOLECULAR MODEL; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; BINDING SITES; FENTANYL; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034628575     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9903702     Document Type: Article

References (112)

1. Janssen, P. A. J. A Review of the Chemical Features Associated with Strong Morphine-like Activity. Br. J. Anaesth. 1962, 34, 260-268.
2. (a) Helsley, G. C.; Lunsford, C. D.; Welstead, W. J., Jr.; Boswell, R. F.; Funderburk, W. H.; Johnson, D. N. Synthesis and Analgesic Activity of Some 1-substituted 3-pyrroldinylanilides and dihydrobenzoxazinones. J. Med. Chem. 1969, 12, 583-586.
3. (b) van Bever, W. F. M.; Niemegeers, C. J. E.; Janssen, P. A. J. Synthetic Analgesics. Synthesis and Pharmacology of the Diastereoisomers of N-[3-Methyl-1-(2-phenethyl)-4-piperidyl]-N-phenylpropanamide and N-[3-Methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl]-N-phenylpropanamide. J. Med. Chem. 1974, 17, 1047-1051.
4. (c) Finney, Z. G.; Riley, T. N. 4-Anilidopiperidine Analgesics. 3. 1-Substituted 4-(Propananilido)perhydroazepines as Ring-Expanded Analogues. J. Med. Chem. 1980, 23, 895-899.
5. (d) Borne, R. F.; Law, S.-Y.; Kapeghian, J. C.; Masten, L. W. Evaluation of 2-Azabicyclo[2.2.2]octane Analogues of 4-Anilidopiperidine Analgesics. J. Pharm. Sci. 1980, 69, 1104-1106.
6. (e) Maryanoff, B. E.; Simon, E. J.; Gioannini, T.; Gorissen, H. Potential Affinity Labels for the Opiate Receptor Based on Fentanyl and Related Compounds. J. Med. Chem. 1982, 25, 913-919.
7. (f) Fernandez, M. J.; Huertas, R. M.; Galvez, E.; Orjales, A.; Berisa, A.; Labeaga, L.; Gago, F.; Fonseca, I.; Sanz-Aparicio, J.; Cano, F. H.; Albert, A.; Fayor, J. Synthesis, and Structural, Conformational and Pharmacolgical Studies of New Fentanyl Derivatives of the Norgranatane System. J. Chem. Soc., Perkin Trans. 2 1992, 687-695.
8. (a) Martin, W. R. Pharmacology of Opioids. Pharmacol. Rev. 1983, 35, 283-323.
9. (b) Millan, M. J. Multiple Opioid systems and Pain. Pain 1986, 27, 303-347.
10. (c) Lenz, G. R.; Evans, S. M.; Walters, D. E.; Hopfinger, A. J. Opiates; Academic Press: New York, 1986.
11. (d) Jaffe, J. H.; Martin, W. R. Opioid Analgesics and Antagonists. In The Pharmacological Basis of Therapeutics, 8th ed.; Gilman, A. G., Rall, T. W., Nies, A. S., Taylor, P., Eds.; Pergamon Press: New York, 1990; pp 485-521.
12. (e) Raynor, K.; Kong, H.; Chen, Y.; Yasuda, K.; Yu, L.; Bell, G. I.; Reisine, T. Pharmacological Characterization of the Cloned κ-, δ-, and μ-opioid Receptors. Mol. Pharmacol. 1994, 45, 330-334.
13. (f) Satoh, M.; Minami, M. Molecular Pharmacology of the Opioid Receptors. Pharmacol. Ther. 1995, 68, 343-364.
14. (g) Kieffer, B. L. Recent Advances in Molecular Recognition and Signal Transduction of Active Peptides: Receptors for Opioid Peptides. Cell. Mol. Neurobiol. 1995, 15, 615-635.
15. (h) Dhawan, B. N.; Cesselin, F.; Raghubir, R.; Reisine, T.; Bradley, P. B.; Portoghese, P. S.; Hamon, M. International Union of Pharmacology. XII. Classification of Opioid Receptors. Pharmacol. Rev. 1996, 48, 567-592.
16. (a) Colapet, J. A.; Diamantidis, G.; Spencer, H. K.; Spaulding, T. C.; Rudo, F. G. Synthesis and Pharmacological Evaluation of 4,4-Disubstituted Piperidines. J. Med. Chem. 1989, 32, 968-974.
17. (b) France, C. P.; Winger, G.; Madzihradsky, F.; Seggel, M. G.; Rice, K. C.; Woods, J. H. Mirfentanil: Pharmacological Profile of a Novel Fentanyl Derivative with Opioid and Nonopioid Effects. J. Pharmacol. Exp. Ther. 1991, 258, 502-510.
18. (c) France, C. P.; Gerak, L. R.; Flynn, D.; Winger, G. D.; Medzihradsky, F.; Bagley, J. R.; Brockunier, L. L.; Woods, J. H. Behavioral Effects and Receptor Binding Affinities of Fentanyl Derivatives in Rhesus Monkeys. J. Pharmacol. Exp. Ther. 1995, 274, 17-28.
19. Strand, F. L. Neuropeptides: Regulators of Physiological Processes; MIT Press: Cambridge, 1999; Chapter 14 and references therein.
20. (a) Lobbezoo, M. W.; Soudijn, W.; van Wijngaarden, I. Structure and Receptor Interactions of Morphinomimetics. Part I. Hydroxy and Methoxy Derivatives of Fentanyl and some Morphine Analogues. Eur. J. Med. Chem - Chim. Ther. 1980, 15, 357-361.
21. (b) Lobbezoo, M. W.; Soudijn, W.; van Wijngaarden, I. Opiate Receptor Interaction of Compounds Derived from or Structurally Related to Fentanyl. J. Med. Chem. 1981, 24, 777-782.
22. (a) Casy, A. F.; Hassan, M. M. A.; Simmonds, A. B.; Staniforth, D. Structure-activity Relations in Analgesics Based on 4-anilinopiperidine. J. Pharm. Pharmacol. 1969, 21, 434-440.
23. (b) Maguire, P.; Tsai, N.; Kamal, J.; Cometta-Morini, C.; Upton, C.; Loew, G. Pharmacological Profiles of Fentanyl Analogues at μ, δ and κ Opiate Receptors. Eur. J. Pharmacol. 1992, 273, 219-225.
24. Feldman, P. L.; James, M. K.; Brackeen, M. F.; Bilotta, J. M.; Schuster, S. V.; Lahey, A. P.; Lutz, M. W.; Johnson, M. R.; Leighton, H. F. Design, Synthesis, and Pharmacological Evaluation of Ultrashort- to Long-Acting Opioid Analgetics. J. Med. Chem. 1991, 34, 2202-2208 and references therein.
25. van Bever, W. F. M.; Niemegeers, C. J. E.; Schellekens, K. H. L.; Janssen, P. A. J. N-4-Substituted 1-(2-Arylethyl)-4-piperidinyl-N-phenylpropanamides, a Novel Series of Extremely Potent Analgesics with Unusually High Safety Margin. Arzneim-Forsch. 1976, 26, 1548-1551.
26. van Daele, P. G. H.; DeBruyn, M. F. L.; Boey, J. M.; Sanczuk, S.; Agten, J. T. M.; Janssen, P. A. J. Synthetic Analgesics: N-(1-[2-Arylethyl]-4-substituted 4-piperidinyl) N-Arylalkanamides. Arzneim-Forsch. 1976, 26, 1521-1526.
27. Wang, Z.-X.; Zhu, Y.-C.; Chen, Z.-J.; Ji, R.-Y. Stereoisomers of 3-Methylfentanyl: Synthesis, Absolute Conformation and Analgesic Activity. Acta Pharm. Sin. 1993, 28, 905-910.
28. (a) Band, L.; Xu, H.; Bykov, V.; Greig, N.; Kim, C.-H.; Newman, A.; Jacobson, A. E.; Rice, K. C.; Rothman, R. B. The Potent Opioid Agonist, (+)-cis-3-Methylfentanyl Bind Pseudoirreversibly to the Opioid Receptor Complex in vitro and in vivo: Evidence for a Novel Mechanism of Action. Life Sci. 1990, 47, 2231-2240.
29. (b) Xu, H.; Kim, C.-H.; Zhu, Y. C.; Weber, R. J.; Jacobson, A. E.; Rice, K. C.; Rothman, R. B. (+)-cis-3-Methylfentanyl and its Analogues Bind Pseudoirreversibly to the Mu Opioid Binding Site: Evidence for Pseudoallosteric Modulation. Neuropharmacology 1991, 30, 455-462.
30. Jin, W.-Q.; Xu, H.; Zhu, Y.-C.; Fang, S.-N.; Xia, X.-L.; Huang, Z.-M.; Ge, B.-L.; Chi, Z.-Q. Studies on Synthesis and Relationship Between Analgesic Activity and Receptor Affinity for 3-Methylfentanyl Derivatives. Sci. Sin. 1981, 24, 710-720.
31. (a) Xu, H.; Jie, C.; Chi, Z.-Q. Ohmefentanyl - A New Agonist for μ-opiate Receptor. Sci. Sin. 1985, 28, 504-511.
32. (b) Brine, G. A.; Stark, P. A.; Carroll, F. I.; Xu, H.; Rothman, R. B. Enantiomers of (±)-cis-N-[1-(2-Hydroxy-2-phenylethyl)-3-methyl-4-piperidyl]-N- phenylpropanamide Influence of the Hydroxyl Group. Med. Chem. Res. 1992, 2, 34-40.
33. (c) Ni, Q.; Xu, H.; Partilla, J. S.; Stark, P. A.; Carroll, F. I.; Brine, G. A.; Rothman, R. B. Stereochemical Requirements for Pseudoirreversible Inhibition of Mu Receptor Binding by the 3-Methylfentanyl Congeners, RTI-46144 and its Enantiomers: Evidence for Different Binding Domains. Synapse 1993, 15, 296-306.
34. (d) Wang, Z.-X.; Zhu, Y.-C.; Chen, X.-J.; Ji, R.-Y. Ohmefentanyl Enantiomers and its Analgesic Activity. Chin. Sci. Bull. 1994, 9, 2004-2008.
35. (e) Wang, Z.-X.; Zhu, Y.-C.; Jin, W.-Q.; Chen, X.-J.; Chen, J.; Ji, R.-Y.; Chi, Z.-Q. Stereoisomers of N-[1(2-Hydroxy-2-phenylethyl)-3-methyl-4-piperidyl]-N-phenylpropanamides: Synthesis, Stereochemistry, Analgesic Activity, and Opioid Receptor Binding Characteristics. J. Med. Chem. 1995, 38, 3652-3659.
36. (f) Lu, Y.-F.; Xu, H.; Partilla, J. S.; Brine, G. A.; Carroll, F. I.; Rice, K. C.; Sadee, W.; Rothman, R. B. Opioid Peptide Receptor Studies. 5. Further Evidence that the Methylfentanyl Congener RTI-4614-4 and its Four Stereoisomers Bind to Different Domains of the Rat μ-opioid Receptor. Analgesia 1996, 2, 291-297.
37. 35S]GTP-γ-S Binding Using Cloned μ-opioid Receptors. Analgesia 1997, 3, 35-42.
38. (a) Niemegeers, C. J. E.; Schellekens, K. H. L.; van Bever, W. F. M.; Janssen, P. A. J. Sufentanil, a very Potent and Extremely Safe Intravenous Morphine-like Compound in Mice, Rats, and Dogs. Arzneiml-Forsch. 1976, 26, 1551-1556.
39. (b) Monk, J. P.; Beresford, R.; Ward, A. Sufentanil: A Review of its Pharmacological Properties and Therapeutic Use. Drugs 1988, 36, 286-313.
40. (a) James, M. K.; Feldman, P. L.; Schuster, S. V.; Bilotta, J. M.; Brackeen, M. F.; Leighton, H. J. Opioid Receptor Activity of GI 87084B, A Novel Ultra-short Acting Analgesic in Isolated Tissues. J. Pharmacol. Exp. Ther. 1991, 259, 712-718.
41. (b) Glass, P. S. A. Remifentanil: A New Opioid. J. Clin. Anes. 1995, 7, 558-563.
42. (c) Scholz, J.; Steinfath, M. Ist Remifentanil ein Ideales Opioid für das anästhesiologische Management im 21. Jahrhundert? Anästhesiol Intensivmed. Notfallmed. Schmerzther. 1996, 31, 592-607.
43. James, M. K.; Vuong, A.; Grizzle, M. K.; Shuster, S. V.; Shaffer, J. E.; Hemodynamic Effects of GI 87084B, An Ultra-short Acting Mu-opioid Analgesic in Anesthetized Dogs. J. Pharmacol. Exp. Ther. 1992, 263, 84-91.
44. Zhu, J.; Xue, J.-C.; Law, P.-Y.; Claude, P. A.; Luo, L.-Y.; Yin, J.-L.; Chen, C.-G.; Liu-Chen, L.-Y. The Region in the μ Opioid Receptor Conferring Selectivity for Sufentanil over the δ Receptor is Different from that over the κ Receptor. FEBS Lett. 1996, 384, 198-202.
45. Heerding, J.; Raynor, K.; Kong, H.; Yu, L.; Reisine, T. Mutagenesis Reveals that Agonists and Peptide Antagonists Bind in Fundamentally Distinct Manners to the Rat Mu Receptor than do Nonpeptide Antagonists. Reg. Pept. 1994, 54, 119-120.
46. (a) Mansour, A.; Taylor, L. P.; Fine, J. L.; Thompson, R. C.; Hoversten, M. T.; Mosberg, H. I.; Watson, S. J.; Akil, H. Key Residues Defining the μ-opioid Receptor Binding Pocket: A Site-directed Mutagenesis Study. J. Neurochem. 1997, 68, 344-353.
47. (b) Bot, G.; Blake, A. D.; Li, S.-X.; Resine, T. Fentanyl and its Analogues Desensitize the Cloned Mu Opioid Receptor. J. Pharmacol. Exp. Ther. 1998, 285, 1207-1218.
48. Lu, Y.-F.; Xu, H.; Liu-Chen, L.-Y.; Chen, C.-G.; Partilla, J. S.; Brine, G. A.; Carroll, F. I.; Rice, K. C.; Lai, J.; Porreca, F.; Sadee, W.; Rothman, R. B. Opioid Peptide Receptor Studies. 7. The Methylfentanyl Congener RTI-4614-4 and its Four Enantiomers Bind to Different Domains of the rat μ Opioid Receptor. Synapse 1998, 28, 117-124.
49. Pogozheva, I. D.; Lomize, A. L.; Mosberg, H. I. Opioid Receptor Three-dimensional Structures from Distance Geometry Calculations with Hydrogen Bonding Constraints. Biophys. J. 1998, 75, 612-634.
50. Tollenaere, J. P.; Moereels, H.; van Loon, M. On Conformation Analysis, Molecular Graphics, Fentanyl and its Derivatives. Prog. Drug Res. 1986, 30, 91-126.
51. Brandt, W.; Barth, A.; Höltje, H.-D. A New Consistent Model Explaining Structure (Conformation)-activity Relationships of Opiates with μ-selectivity. Drug Des. Discov. 1993, 10, 257-283.
52. Martins, J.; Andrews, P. Conformation-activity Relationships of Opiate Analgesics. J. Comput.-Aided Mol. Des. 1987, 1, 53-72.
53. (a) Cometta-Morini, C.; Loew, G. H. Development of a Conformational Search Strategy for Flexible Ligands: A Study of the Potent μ-selective Opioid Analgesic Fentanyl. J. Comput.-Aided Mol. Des. 1991, 5, 335-356 and references therein.
54. (b) Cometta-Morini, C.; Maguire, P. A.; Loew, G. H. Molecular Determinants of μ Receptor Recognition for the Fentanyl Class of Compounds. Mol. Pharmacol. 1992, 41, 185-196.
55. Rong, S.-B.; Zhu, Y.-C.; Jiang, H.-L.; Wang, Q.-M.; Zhao, S.-R.; Chen, K.-X.; Ji, R.-Y. Interaction Models of 3-Methylfentanyl Derivatives with μ Opioid Receptors. Acta Pharmacol. Sin. 1997, 18, 128-132.
56. Baldwin, J. M.; Schertler, G. F. X.; Unger, V. M. An Alpha-carbon Template for the Transmembrane Helices in the Rhodopsin Family of G-protein-coupled Receptors. J. Mol. Biol. 1997, 272, 144-164.
57. (a) Paterlini, G.; Portoghese, P. S.; Ferguson, D. M. Molecular Simulation of Dynorphin A(1-10) Binding to Extracellular Loop 2 of the κ-opioid Receptor. A Model for Receptor Activitation. J. Med. Chem. 1997, 40, 3254-3262.
58. (b) Subramanian, G.; Paterlini, M. G.; Larson, D. L.; Portoghese, P. S.; Ferguson, D. M. Conformational Analysis and Automated Receptor Docking of Selective Arylacetamide-Based κ-opioid Agonists. J. Med. Chem. 1998, 41, 4777-4789.
59. Unger, V. M.; Hargrave, P. A.; Baldwin, J. M.; Schertler, G. F. X. Arrangement of Rhodopsin Transmembrane Alpha Helices Obtained by Electron Cryo-microscopy. Nature 1997, 389, 203-206.
60. Metzger, T. G.; Paterlini, M. G.; Portoghese, P. S.; Ferguson, D. M. Application of the Message-Address Concept of the Docking of Naltrexone and Selective Naltrexone-Derived Opioid Antagonists into Opioid Receptor Models. Neurochem. Res. 1996, 21, 1287-1294.
61. Dunbrack, R. L., Jr.; Karplus, M. Backbone-dependent Rotamer Library for Proteins. Application to Side-chain Prediction. J. Mol. Biol. 1993, 230, 543-574.
62. Xu, W.; Ozdener, F.; Li, J.-G.; Chen, C.; de Riel, J. K.; Weinstein, H.; Liu-Chen, L.-Y. Functional Role of the Spatial Proximity of Asp114(2.50) in TMH 2 and Asn332(7.49) in TMH 7 of the μ Opioid Receptor. FEBS Lett. 1999, 447, 318-324.
63. Zhou, W.; Flanaga, C., Ballesteros, J. A.; Konvicka, K.; Davidson, J. A.; Weinstein, H.; Millar, R. P.; Sealfon, S. C. A Reciprocal Mutation Supports Helix 2 and Helix 7 Proximity in the Gonadotropin-releasing Hormone Receptor. Mol. Pharmacol. 1994, 45, 165-170.
64. Javitch, J. A.; Fu, D.; Chen, J. Residues in the Fifth Membrane-spanning Segment of the Dopamine D2 Receptor Exposed in the Binding-site Crevice. Biochemistry 1995, 34, 16433-16439.
65. Perlman, J. H.; Colson, A. O.; Wang, W.; Bence, K.; Osman, R.; Gershengorn, M. C. Interaction Between Conserved Residues in Transmembrane Helices 1, 2, and 7 of the Thyrotropin-releasing Hormone Receptor. J. Biol. Chem. 1997, 272, 11937-11942.
66. Thirstrup, K.; Elling, C. E.; Hjorth, S. A.; Schwartz, T. W. Construction of a High Affinity Zinc Switch in the κ-opioid Receptor. J. Biol. Chem. 1996, 271, 7875-7878.
67. Laskowski, R. A.; MacArthur, M. W.; Moss, D. S.; Thorton, J. M. PROCHECK: A Program to Check the Stereochemical Quality of Protein Structures. J. Appl. Crystallogr. 1993, 26, 283-291.
68. Peeters, O. M.; Blaton, N. M.; De Ranter, C. J.; van Herk, A. M.; Goubitz, K. Crystal and Molecular Structure of N-[1-(2-phenylethyl)-4-piperidinylium]-N-phenylpropanamide (fentanyl) citrate-toluene Solvate. J. Cryst. Mol. Struct. 1979, 9, 153-161.
69. Koch, M. H. J.; De Ranter, C. J.; Rolies, M.; Dideberg, O. Acta Crystallogr. 1976, B32, 2529.
70. Flippen-Anderson, J. L.; George, C.; Bertha, C. M.; Rice, K. C. X-ray Crystal Structures of Potent Opioid Receptor Ligands: Etonitazene, cis-(+)-3-Methylfentanyl, Etorphine, Diprenorphine, and Buprenorphine. Heterocycles 1994, 39, 751-766.
71. Brine, G. A.; Stark, P. A.; Liu, Y.; Carroll, F. I.; Singh, P.; Xu, H.; Rothman, R. B. Enantiomers of Diastereomeric cis-N-[1-(2-Hydroxy-2-phenylethyl)-3-methyl-4-piperidyl]-N-phenylpropana-mides: Synthesis, X-ray Analysis, and Biological Activities. J. Med. Chem. 1995, 38, 1547-1557.
72. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Gill, P. M. W.; Johnson, B. G.; Robb, M. A.; Cheeseman, J. R.; Keith, T.; Petersson, G. A.; Montgomery, J. A.; Raghavachari, K.; Al-Laham, M. A.; Zakrzewski, V. G.; Ortiz, J. V.; Foresman, J. B.; Cioslowski, J.; Stefanov, B. B.; Nanayakkara, A.; Challacombe, M.; Peng, C. Y.; Ayala, P. Y.; Chen, W.; Wong, M. W.; Andres, J. L.; Replogle, E. S.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Binkley, J. S.; Defrees, D. J.; Baker, J.; Stewart, J. J. P.; Head-Gordon, M.; Gonzalez, C.; Pople, J. A. Gaussian94, revision E2; Gaussian Inc.: Pittsburgh, PA, 1995.
73. Cieplak, P.; Cornell, W. D.; Bayly, C.; Kollman, P. A. Application of the Multimolecule and Multiconformational RESP Methodology to Biopolymers: Charge Derivation for DNA, RNA, and Proteins. J. Comput. Chem. 1995, 16, 1357-1377.
74. Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Gould, I. R.; Merz, K. M., Jr.; Ferguson, D. M.; Spellmeyer, D. C.; Fox, T.; Caldwell, J. W.; Kollman, P. A. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules. J. Am. Chem. Soc. 1995, 117, 5179-5197.
75. (a) Pearlman, D. A.; Case, D. A.; Caldwell, J. W.; Ross, W. S.; Cheatham, T. E., III; Debolt, S.; Ferguson, D. M.; Seibel, G. L.; Kollman, P. A. AMBER, a Package of Computer Programs for Applying Molecular Mechanics, Normal-mode Analysis, Molecular Dynamics, and Free Energy Calculations to Simulate the Structural and Energetic Properties of Molecules. Comput. Phys. Commun. 1995, 91, 1-41.
76. (b) Pearlman, D. A.; Case, D. A.; Caldwell, J. W.; Ross, W. S.; Cheatham, T. E., III; Ferguson, D. M.; Seibel, G. L.; Singh, U. C.; Weiner, P. K.; Kollman, P. A. AMBER, version 4.1; Department of Pharmaceutical Chemistry, University of California: San Fransisco, CA, 1995.
77. Fox, T.; Scanlan, T. S.; Kollman, P. A. Ligand Binding in the Catalytic Antibody 17E8. A Free Energy Perturbation Calculation Study. J. Am. Chem. Soc. 1997, 119, 11571-11577.
78. Jorgenson, W. L.; Chandrasekhar, J.; Madhura, J. D.; Impey, R. W.; Klein, M. L. Comparison of Simple Potential Functions for Simulating Liquid Water. J. Chem. Phys. 1983, 79, 926-935.
79. Berendsen, H. J. C.; Postma, J. P. M.; van Gunsteren, W. F.; DiNola, A.; Haak, J. R. Molecular Dynamics with Coupling to an External Bath. J. Chem. Phys. 1984, 81, 3684-3690.
80. (a) Meng, E. C.; Shoichet, B. K.; Kuntz, I. D. Automated Docking with Grid-based Energy Evaluation. J. Comput. Chem. 1992, 13, 505-524.
81. (b) Meng, E. C.; Gschwend, D. A.; Blaney, J. M.; Kuntz, I. D. Orientational Sampling and Rigid-body Minimization in Molecular Docking. Proteins: Struct. Funct. Genet. 1993, 17, 266-278.
82. (c) Connolly, M.; Gschwend, D. A.; Good, A. C.; Oshiro, C.; Kuntz, I. D. DOCK, version 3.5; Department of Pharmaceutical Chemistry, University of California: San Francisco, CA, 1995.
83. (a) Connolly, M. L. Solvent-accessible Surfaces of Proteins and Nucleic Acids. Science 1983, 221, 709-713.
84. (b) Connolly, M. L. Analytical Molecular Surface Calculation. J. Appl. Crystallogr. 1983, 16, 548-558.
85. (a) Surratt, C. K.; Johnson, P. S.; Moriwaki, A.; Seidleck, B. K.; Blaschak, C. J.; Wang, J. B.; Uhl, G. R. μ Opiate Receptor. J. Biol. Chem. 1994, 269, 20548-20553.
86. (b) Befort, K.; Tabbara, L.; Bausch, S.; Chavkin, C.; Evans, C.; Kieffer, B. The Conserved Aspartate Residue in the Third Putative Transmembrane Domain of the μ-opioid Receptor is not the Anionic Counterpart for Cationic Opiate Binding but is a Constituent of the Receptor Binding Site. Mol. Pharmacol. 1996, 49, 216-223.
87. (a) Castiglione-Morelli, M. A.; Lelj, F.; Pastore, A.; Salvadori, S.; Tancredi, T.; Tomatis, R.; Trivellone, E. A 500-MHz Proton Nuclear Magnetic Resonance Study of μ Opioid Peptides in a Simulated Receptor Environment. J. Med. Chem. 1987, 30, 2067-2073.
88. (b) Brine, G. A.; Boldt, K. G.; Huang, P.-T.; Sawyer, D. K.; Carroll, F. I. Carbon-13 Nuclear Magnetic Resonance Spectra of Fentanyl Analogues. J. Heterocycl. Chem. 1989, 26, 677-686.
89. +] solution conformations for 4 and 6 resulted in initial docking arrangements where the ligands occupied the larger pocket between TM-III and -V-VII helices and are not consistent with experimental point mutation results and the binding modes of other members in this series.
90. Hjorth, S. A.; Thirstrup, K.; Grandy, D. K.; Schwartz, T. W. Analysis of Selective Binding Epitopes for the κ-opioid Receptor Antagonist Nor-binaltorphimine. Mol. Pharmacol. 1996, 47, 1089-1094.
91. (a) Jones, R. M.; Hjorth, S. A.; Schwartz, T. W.; Portoghese, P. S. Mutational Evidence for a Common κ Antagonist Binding Pocket in the Wild-type κ and Mutant κ[K303E] Opioid Receptors. J. Med. Chem. 1998, 41, 4911-4914.
92. (b) Stevens, W. C., Jr.; Jones, R. M.; Subramanian, G.; Metzger, T. G.; Ferguson, D. M.; Portoghese, P. S. Potent and Selective Indolomorphinan Antagonists of the κ-Opioid Receptor. J. Med. Chem., manuscript in preparation.
93. Valiquette, M.; Vu, H. K.; Vue, S. Y.; Wahlestedt, C.; Walker, P. Involvement of Trp-284, Val-296, and Val-297 of the Human δ-opioid Receptor Binding of δ-selective Ligands. J. Biol. Chem. 1996, 271, 18789-18796.
94. Kong, H.; Raynor, K.; Reisine, T. Amino Acids in the Cloned Mouse Kappa Receptor That are Necessary for High Affinity Agonist Binding but not Antagonist Binding. Reg. Pept. 1994, 54, 155-156.
95. Spivak, C. E.; Beglan, C. L.; Seidleck, B. K.; Hirshbein, L. D.; Blaschak, C. J.; Uhl, G. R.; Surratt, C. K. Naloxone Activation of μ-opioid Receptors Mutated at a Histidine Residue Lining the Opioid Binding Cavity. Mol. Pharmacol. 1997, 52, 983-992.
96. Tang, Y.; Chen, K. X.; Jiang, H. L.; Wang, Z. X.; Ji, R. Y.; Chi, Z. Q. Molecular Modeling of μ Opioid Receptor and its Interaction with Ohmefentanyl. Acta Pharmacol. Sin. 1996, 17, 156-160.
97. Xu, H.; Lu, Y.-F.; Partilla, J. S.; Zheng, Q.-X.; Wang, J.-B.; Brine, G. A.; Carroll, I.; Rice, K. C.; Chen, K.-X.; Chi, Z.-Q.; Rothman, R. B. Opioid Peptide Receptor Studies, 11: Involvement of Tyr148, Trp318 and His319 of the Rat μ-Opioid Receptor in Binding of μ-Selective Ligands. Synapse 1999, 32, 23-28.
98. Riley, T. N.; Hale, D. B.; Wilson, M. C. 4-Anilidopiperidine Analgesics I: Synthesis and Analgesic Activity of Certain Ring-methylated 1-substituted 4-propananilidopiperidines. J. Pharm. Sci. 1973, 62, 983-986.
99. Casy, A. F.; Ogungbamila, F. O. 3-Allyl and 3-Propyl Analogues of Fentanyl. Eur. J. Med. Chem. - Chim. Ther. 1983, 18, 56-60.
100. Maryanoff, B. E.; McComsey, D. F.; Taylor, R. J., Jr.; Gardocki, J. F. Synthesis and Stereochemistry of 7-Phenyl-2-propionanilidobenzo[α]quinolizidine Derivatives. Structural Probes for Fentanyl Analgesics. J. Med. Chem. 1981, 24, 79-88.
101. Bagley, J. R.; Thomas, S. A.; Rudo, F. G.; Spencer, H. K.; Doorley, B. M.; Ossipov, M. H.; Jerussi, T. P.; Benvenga, M. J.; Spaulding, T. New 1-(Heterocyclylalkyl)-4-propionanilido-4-piperidinyl Methyl Ester and Methylene Methyl Ether Analgesics. J. Med. Chem. 1991, 34, 827-841.
102. (a) Janssen, P. A. J.; van der Eycken, C. A. M. The Chemical Anatomy of Potent Morphine like Analgesics. In Drugs Affecting the CNS; Burger, A., Ed.; Dekker: New York, 1968; Vol. 2, pp 25-60.
103. (b) Klein, W.; Back, W.; Mutschler, E. Uber die Synthese und Pharmakalogische Wirkung Cyclischer Analoga des Fentanyl. Arch. Pharm. 1975, 308, 910-914.
104. (c) Berger, J. G.; Davidson, F.; Langford, G. E. Synthesis of Some Conformationally Restricted Analogues of Fentanyl. J. Med. Chem. 1977, 20, 600-602.
105. (d) Borne, R. F.; Fifer, E. K.; Waters, I. W. Conformationally Restrained Fentanyl Analogues. 2. Synthesis and Analgetic Evaluation of Perhydro-1,6-naphthyridin-2-ones. J. Med. Chem. 1984, 27, 1271-1275.
106. (a) Clark, R. L.; Pessolano, A. A.; Weijlard, J.; Pfister, K. N-substituted Epoxymorphinans. J. Am. Chem. Soc. 1953, 75, 4963-4967.
107. (b) Winter, C. A.; Orahovats, P. D.; Lehman, E. G. Analgesic Activity and Morphine Antagonism of Compounds Related to Nalorphine. Arch. Int. Pharmacodyn. 1957, CX, 186-202.
108. Kong, H.; Raynor, K.; Yasuda, K.; Moe, S. T.; Portoghese, P. S.; Bell, G. I.; Reisine, T. A Single Residue, Aspartic Acid 95, in the δ Opioid Receptor Specifies Selective High Affinity Agonist Binding. J. Biol. Chem. 1993, 268, 23055-23058.
109. Shieh, T.; Han, M.; Sakmar, T. P.; Smith, S. O. The Steric Trigger in Rhodopsin Activation. J. Mol. Biol. 1997, 269, 373-384.
110. (a) Bagley, J. R.; Wynn, R. L.; Rudo, F. G.; Doorley, B. M.; Spencer, H. K.; Spaulding, T. New 4-(Heteroanilido)piperidines, Structurally Related to the Pure Opioid Agonist Fentanyl, with Agonist and/or Antagonist Properties. J. Med. Chem. 1989, 32, 663-671.
111. (b) Kudzma, L. V.; Severnak, S. A.; Benvenga, M. J.; Ezell, E. F.; Ossipov, M. H.; Knight, V. V.; Rudo, F. G.; Spencer, H. K.; Spaulding, T. C. 4-Phenyl- and 4-Heteroaryl-4-anilidopiperidines. A Novel Class of Analgesic and Anesthetic Agents. J. Med. Chem. 1989, 32, 2534-2542.
112. (c) France, C. P.; Ahn, S. C.; Brockunier, L. L.; Bagley, J. R.; Brandt, M. R.; Winsauer, P. J.; Moerschbaecher, J. M. Behavioral Effects and Binding Affinities of the Fentanyl Derivative OHM3507. Pharmacol. Biochem. Behav. 1998, 59, 295-303.